牛叉诊股

[{"date":"2026.04.17","stock":"-2.70","trade":"-1.52","ind":"0.60"},{"date":"2026.04.16","stock":"0.80","trade":"-0.13","ind":"2.05"},{"date":"2026.04.15","stock":"2.80","trade":"2.03","ind":"-0.97"},{"date":"2026.04.14","stock":"0.00","trade":"0.36","ind":"1.61"},{"date":"2026.04.13","stock":"-1.14","trade":"-1.82","ind":"0.69"},{"date":"2026.04.10","stock":"0.16","trade":"0.01","ind":"2.24"},{"date":"2026.04.09","stock":"-3.46","trade":"-1.54","ind":"-0.33"},{"date":"2026.04.08","stock":"0.95","trade":"0.62","ind":"4.79"},{"date":"2026.04.07","stock":"2.27","trade":"0.87","ind":"0.36"},{"date":"2026.04.03","stock":"-4.64","trade":"-2.39","ind":"-0.99"},{"date":"2026.04.02","stock":"0.47","trade":"0.62","ind":"-1.60"},{"date":"2026.04.01","stock":"5.41","trade":"2.36","ind":"1.70"},{"date":"2026.03.31","stock":"-1.61","trade":"-0.69","ind":"-1.81"},{"date":"2026.03.30","stock":"-0.32","trade":"1.18","ind":"-0.25"},{"date":"2026.03.27","stock":"4.19","trade":"2.53","ind":"1.13"},{"date":"2026.03.26","stock":"-3.08","trade":"-0.80","ind":"-1.41"},{"date":"2026.03.25","stock":"5.48","trade":"1.38","ind":"1.95"},{"date":"2026.03.24","stock":"5.23","trade":"3.44","ind":"1.43"},{"date":"2026.03.23","stock":"-4.64","trade":"-5.85","ind":"-3.76"},{"date":"2026.03.20","stock":"-0.85","trade":"-1.99","ind":"-0.25"},{"date":"2026.03.19","stock":"-2.49","trade":"-1.92","ind":"-2.02"}]

振东制药,深证成指,中药指数

压力支撑

该股压力位为6.17元，支撑位为6.07元。

[{"text":"\u538b\u529b\u4f4d","value":"6.17","date":1776355200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"6.07","date":1776355200,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.0资金面打败了4%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：04月17日 20:30

机构今日流向(万元)	-3130.77	机构5日流向(万元)	-5156.47
机构10日流向(万元)	-12326.39	机构20日流向(万元)	-10668.01

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少38328.28万股，其中基金净减仓4家，主力净增仓33家，暂未发现中长期投资价值。

截止2025-12-31，共50家主力机构（基金50家），持仓量总计799.65万股，占流通A股0.80%
其中，基金持仓与2025-06-30相比：
增仓：1家，增持 4.07万股
减仓：5家，减持 26.42万股
新出现在主力名单中：44家，持有758.48万股
从主力名单中消失：11家，原持有39064.41万股

消息面诊股

诊断结果：5.6消息面打败了31%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2026-04-09
利好	业绩预告	预计减亏	2026-01-23
一般消息	高管变动	因工作岗位调动	2025-12-31
一般消息	重大事项	公司股东股份解押	2025-12-19
一般消息	高管变动	因达到法定退休年龄	2025-12-18
一般消息	重大事项	公司股东股份解押	2025-11-26
一般消息	重大事项	公司股东股份解押	2025-11-03
一般消息	重大事项	公司股东股份解押	2025-10-09
一般消息	重大事项	公司股东股份解押	2025-09-09
一般消息	分红转增	不分配不转增	2025-08-25
一般消息	重大事项	公司股东股份解押	2025-07-30
一般消息	重大事项	公司股东股份解押	2025-07-18
一般消息	重大事项	公司股东股份解押	2025-07-03
一般消息	重大事项	关联交易	2025-05-14
一般消息	分红转增	不分配不转增	2025-04-21
一般消息	重大事项	关联交易	2025-04-21
一般消息	重大事项	公司股东股份解押	2025-04-21
一般消息	高管变动	因个人原因	2025-04-18

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：5.7行业面打败了69%的股票中药行业最新资金流向

近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.04.17","price":"0.60","value":"-1.52"},{"date":"2026.04.16","price":"2.05","value":"-0.13"},{"date":"2026.04.15","price":"-0.97","value":"2.03"},{"date":"2026.04.14","price":"1.61","value":"0.36"},{"date":"2026.04.13","price":"0.69","value":"-1.82"},{"date":"2026.04.10","price":"2.24","value":"0.01"},{"date":"2026.04.09","price":"-0.33","value":"-1.54"},{"date":"2026.04.08","price":"4.79","value":"0.62"},{"date":"2026.04.07","price":"0.36","value":"0.87"},{"date":"2026.04.03","price":"-0.99","value":"-2.39"},{"date":"2026.04.02","price":"-1.60","value":"0.62"},{"date":"2026.04.01","price":"1.70","value":"2.36"},{"date":"2026.03.31","price":"-1.81","value":"-0.69"},{"date":"2026.03.30","price":"-0.25","value":"1.18"},{"date":"2026.03.27","price":"1.13","value":"2.53"},{"date":"2026.03.26","price":"-1.41","value":"-0.80"},{"date":"2026.03.25","price":"1.95","value":"1.38"},{"date":"2026.03.24","price":"1.43","value":"3.44"},{"date":"2026.03.23","price":"-3.76","value":"-5.85"},{"date":"2026.03.20","price":"-0.25","value":"-1.99"},{"date":"2026.03.19","price":"-2.02","value":"-1.92"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	万邦德	55.74%	-1.74%	5.0分
2	沃华医药	19.66%	4.25%	6.1分
3	益佰制药	16.28%	-6.44%	3.6分
4	ST香雪	9.89%	-6.01%	5.6分
5	康惠股份	9.65%	14.35%	5.6分
6	九芝堂	6.61%	-0.63%	4.9分
7	康恩贝	6.61%	5.88%	5.5分
8	健民集团	6.44%	-2.85%	5.3分
9	华润江中	5.39%	3.85%	6.2分
10	ST百灵	5.30%	2.38%	5.1分
11	振东制药	4.43%	-0.33%	4.5分
12	广誉远	3.77%	-1.14%	4.8分
13	ST葫芦娃	3.32%	-1.86%	4.4分
14	华森制药	2.75%	0.28%	5.0分
15	东阿阿胶	2.37%	-1.33%	5.8分
16	嘉应制药	1.95%	0.13%	5.2分
17	亚宝药业	1.84%	-1.34%	5.9分
18	众生药业	1.82%	-0.91%	5.2分
19	红日药业	1.14%	-0.28%	4.8分
20	天士力	1.06%	0.78%	5.2分
21	桂林三金	1.00%	-0.77%	5.6分
22	仁和药业	0.87%	-1.02%	4.8分
23	-	0.61%	2.35%	分
24	以岭药业	0.60%	-0.30%	5.4分
25	-	0.38%	-1.49%	分
26	吉林敖东	0.17%	-0.16%	5.0分
27	步长制药	-0.06%	-0.12%	5.7分
28	太极集团	-0.25%	-1.34%	4.8分
29	康缘药业	-0.50%	0.80%	5.0分
30	精华制药	-0.80%	-2.48%	5.4分
31	葵花药业	-0.81%	-0.16%	4.4分
32	奇正藏药	-0.85%	-0.13%	5.5分
33	陇神戎发	-1.05%	-1.98%	5.3分
34	太龙药业	-1.10%	-0.97%	4.9分
35	华神科技	-1.23%	-1.71%	5.3分
36	粤万年青	-1.29%	-4.83%	4.6分
37	佐力药业	-1.89%	-0.83%	5.1分
38	中恒集团	-1.95%	-3.09%	4.7分
39	汉森制药	-2.07%	-1.19%	5.2分
40	上海凯宝	-2.12%	0.17%	5.3分
41	信邦制药	-2.14%	-1.84%	4.7分
42	特一药业	-2.28%	-2.99%	5.4分
43	恩威医药	-2.30%	-0.38%	5.9分
44	云南白药	-2.54%	0.67%	6.0分
45	千金药业	-2.67%	-1.30%	5.9分
46	三力制药	-2.75%	-0.54%	5.6分
47	达仁堂	-3.28%	-1.02%	5.4分
48	马应龙	-3.58%	-2.75%	5.0分
49	佛慈制药	-3.66%	-2.77%	5.1分
50	维康药业	-4.20%	-2.59%	4.4分
51	羚锐制药	-4.36%	-2.77%	5.2分
52	寿仙谷	-4.63%	-1.07%	5.0分
53	康美药业	-4.89%	-0.57%	5.0分
54	新天药业	-4.94%	-2.92%	4.9分
55	金花股份	-5.48%	-9.40%	4.3分
56	天目药业	-5.62%	-7.11%	5.1分
57	华润三九	-5.66%	-1.15%	5.7分
58	新光药业	-5.68%	-3.36%	4.9分
59	盘龙药业	-5.72%	-3.43%	4.6分
60	昆药集团	-6.29%	-1.24%	4.5分
61	珍宝岛	-6.29%	-1.90%	4.4分
62	片仔癀	-6.81%	-2.91%	4.5分
63	同仁堂	-7.13%	-0.25%	5.2分
64	古汉医药	-7.44%	-1.67%	5.4分
65	益盛药业	-7.72%	-5.28%	5.3分
66	方盛制药	-9.61%	-4.34%	5.2分
67	白云山	-9.67%	-0.61%	5.6分
68	济川药业	-10.21%	-0.92%	5.2分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.2基本面打败了24%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（32.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 53/107 ， 34/107。

[{"date":"2025-09-30","value":"0.55","vol":"4.81"},{"date":"2025-06-30","value":"0.22","vol":"4.04"},{"date":"2025-03-31","value":"0.03","vol":"2.25"},{"date":"2024-12-31","value":"-29.93","vol":"4.87"},{"date":"2024-09-30","value":"0.78","vol":"5.62"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	0.55	0.22	0.03	-29.93	0.78
行业(%)	4.81	4.04	2.25	4.87	5.62

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"52.93","vol":"53.26"},{"date":"2025-06-30","value":"51.15","vol":"53.79"},{"date":"2025-03-31","value":"49.09","vol":"54.43"},{"date":"2024-12-31","value":"47.49","vol":"53.69"},{"date":"2024-09-30","value":"50.87","vol":"53.56"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	52.93	51.15	49.09	47.49	50.87
行业(%)	53.26	53.79	54.43	53.69	53.56

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 27/107 ， 54/107。

[{"date":"2025-09-30","value":"-2.42","vol":"-7.81"},{"date":"2025-06-30","value":"-3.30","vol":"-7.74"},{"date":"2025-03-31","value":"-3.53","vol":"-7.31"},{"date":"2024-12-31","value":"-18.06","vol":"-6.13"},{"date":"2024-09-30","value":"-18.48","vol":"-3.58"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-2.42	-3.30	-3.53	-18.06	-18.48
行业(%)	-7.81	-7.74	-7.31	-6.13	-3.58

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-49.25","vol":"-2.50"},{"date":"2025-06-30","value":"-74.13","vol":"2.58"},{"date":"2025-03-31","value":"-94.99","vol":"-37.35"},{"date":"2024-12-31","value":"-2920.55","vol":"-148.45"},{"date":"2024-09-30","value":"4689.69","vol":"65.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-49.25	-74.13	-94.99	-2920.55	4689.69
行业(%)	-2.50	2.58	-37.35	-148.45	65.47

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 14/107 ， 33/107。

[{"date":"2025-09-30","value":"0.47","vol":"0.35"},{"date":"2025-06-30","value":"0.31","vol":"0.24"},{"date":"2025-03-31","value":"0.16","vol":"0.13"},{"date":"2024-12-31","value":"0.53","vol":"0.50"},{"date":"2024-09-30","value":"0.38","vol":"0.38"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.47	0.31	0.16	0.53	0.38
行业(次)	0.35	0.24	0.13	0.50	0.38

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.45","vol":"1.72"},{"date":"2025-06-30","value":"1.01","vol":"1.17"},{"date":"2025-03-31","value":"0.54","vol":"0.60"},{"date":"2024-12-31","value":"1.58","vol":"2.41"},{"date":"2024-09-30","value":"0.98","vol":"1.81"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.45	1.01	0.54	1.58	0.98
行业(次)	1.72	1.17	0.60	2.41	1.81

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"-26.37","vol":"10.53"},{"date":"2025-06-30","value":"-10.38","vol":"22.82"},{"date":"2025-03-31","value":"-43.74","vol":"2.07"},{"date":"2024-12-31","value":"-5.57","vol":"22.07"},{"date":"2024-09-30","value":"-10.39","vol":"6.09"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	-26.37	-10.38	-43.74	-5.57	-10.39
行业	10.53	22.82	2.07	22.07	6.09

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.14","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.49","vol":"1.48"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	1.14	-	2.49	-
行业	0.00	1.03	0.00	1.48	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 37/107 ， 43/107。

[{"date":"2025-09-30","value":"3.14","vol":"3.09"},{"date":"2025-06-30","value":"3.19","vol":"2.94"},{"date":"2025-03-31","value":"3.03","vol":"3.03"},{"date":"2024-12-31","value":"2.56","vol":"2.92"},{"date":"2024-09-30","value":"5.40","vol":"3.30"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	3.14	3.19	3.03	2.56	5.40
行业	3.09	2.94	3.03	2.92	3.30

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"2.21","vol":"2.24"},{"date":"2025-06-30","value":"2.32","vol":"2.15"},{"date":"2025-03-31","value":"2.26","vol":"2.24"},{"date":"2024-12-31","value":"1.87","vol":"2.13"},{"date":"2024-09-30","value":"3.72","vol":"2.46"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	2.21	2.32	2.26	1.87	3.72
行业	2.24	2.15	2.24	2.13	2.46

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 46/107 ， 49/107。

[{"date":"2025-09-30","value":"19.57","vol":"31.59"},{"date":"2025-06-30","value":"19.59","vol":"32.44"},{"date":"2025-03-31","value":"21.81","vol":"31.90"},{"date":"2024-12-31","value":"26.54","vol":"32.73"},{"date":"2024-09-30","value":"13.63","vol":"32.27"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	19.57	19.59	21.81	26.54	13.63
行业(%)	31.59	32.44	31.90	32.73	32.27

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.24","vol":"0.76"},{"date":"2025-06-30","value":"0.24","vol":"0.75"},{"date":"2025-03-31","value":"0.28","vol":"0.74"},{"date":"2024-12-31","value":"0.36","vol":"0.76"},{"date":"2024-09-30","value":"0.16","vol":"0.73"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.24	0.24	0.28	0.36	0.16
行业(%)	0.76	0.75	0.74	0.76	0.73

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"26.17","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-0.51","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.44","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-13.29","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[振东制药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]